| RS483353079 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS483353081 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS483353082 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS483353085 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS483353086 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS483353090 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS483353091 |
BRCA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS483353092 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS483353093 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS483353095 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS483353099 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS483353100 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS483353102 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS483353103 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS483353108 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS483353110 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS483353111 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS483353112 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS483353114 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS483353115 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS483353118 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS483353119 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS483353122 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS483353127 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS483353128 |
HAND2
|
Health Risk |
Likely pathogenic |
— |
| RS483353129 |
TBX5
|
Health Risk |
Pathogenic |
— |
| RS4851569 |
IL18R1
|
Health Risk |
association |
Behcet disease, Behcet disease |
| RS4851608 |
SLC9A4
|
Health Risk |
association |
Ascending aortic dissection, Ascending aortic dissection |
| RS4876870 |
TNFRSF11B
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperphosphatasemia with bone disease, Hyperphosphatasemia with bone disease |
| RS4880 |
SOD2
|
Health Risk |
Conflicting classifications of pathogenicity; risk factor |
SOD2 POLYMORPHISM, Microvascular complications of diabetes |
| RS4884357 |
TARDBP
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 10, FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS |
| RS4889500 |
SRCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS4889990 |
CARD14
|
Health Risk |
Conflicting classifications of pathogenicity |
Psoriasis 2, Pityriasis rubra pilaris |
| RS4889991 |
CARD14
|
Health Risk |
Conflicting classifications of pathogenicity |
Pityriasis rubra pilaris, Psoriasis 2 |
| RS4939827 |
SMAD7
|
Health Risk |
risk factor |
Colorectal cancer, susceptibility to |
| RS4950928 |
CHI3L1
|
Health Risk |
risk factor |
Asthma-related traits, susceptibility to |
| RS4959085 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8 |
| RS4963152 |
SLC25A22
|
Health Risk |
Conflicting classifications of pathogenicity |
Early myoclonic encephalopathy, Early myoclonic encephalopathy |
| RS4963190 |
RNH1
|
Health Risk |
risk factor |
Encephalitis, acute |
| RS4964059 |
BMAL2
|
Health Risk |
association |
Pulmonary disease, chronic obstructive |
| RS497116 |
CASP12
|
Health Risk |
risk factor |
Sepsis, susceptibility to |
| RS4976 |
ACE
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal tubular dysgenesis, Renal tubular dysgenesis |
| RS4977574 |
CDKN2B-AS1
|
Health Risk |
risk factor |
Three Vessel Coronary Disease, Three Vessel Coronary Disease |
| RS4981473 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS4986847 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS4986849 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS4986852 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS4986933 |
ERCC4
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group F |
| RS4986984 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS4987048 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS4987049 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS4987050 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS4987090 |
XRCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS4987109 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS4987127 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Melanoma-pancreatic cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS4987137 |
CYP1B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital glaucoma, Glaucoma 3A |
| RS4987188 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS4987238 |
WRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Werner syndrome, Inborn genetic diseases |
| RS4988008 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS4988125 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS4988235 |
MCM6
|
Health Risk |
association |
LACTASE PERSISTENCE, LACTASE PERSISTENCE |
| RS4988321 |
LRP5
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteoporosis with pseudoglioma, 8 conditions |
| RS4988345 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS4988349 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS4988352 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group J, Hereditary cancer-predisposing syndrome |
| RS4988356 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS4988460 |
POU1F1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pituitary hormone deficiency, combined |
| RS4988958 |
IL1RL1
|
Health Risk |
association |
Ascending aortic dissection, Ascending aortic dissection |
| RS4995611 |
NLGN4X
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Autism |
| RS4998897 |
CYP11B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of steroid 11-beta-monooxygenase, Glucocorticoid-remediable aldosteronism |
| RS5017568 |
FCGR2B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS5017717 |
PROS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Thrombophilia due to protein S deficiency, autosomal recessive |
| RS5029941 |
TNFAIP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoinflammatory syndrome, familial |
| RS5030400 |
ICAM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malaria, susceptibility to |
| RS5030622 |
VHL
|
Health Risk |
Pathogenic/Likely pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS5030646 |
FSHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypogonadotropic hypogonadism 24 without anosmia, Hypogonadotropic hypogonadism 24 without anosmia |
| RS5030648 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS5030651 |
VHL
|
Health Risk |
Pathogenic |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS5030654 |
PAH
|
Health Risk |
Pathogenic |
Phenylketonuria, Phenylketonuria |
| RS5030730 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Duchenne muscular dystrophy |
| RS5030731 |
HEXB
|
Health Risk |
Pathogenic/Likely pathogenic |
Sandhoff disease, infantile form |
| RS5030737 |
MBL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mannose-binding lectin deficiency, Cystic fibrosis |
| RS5030764 |
GP9
|
Health Risk |
Pathogenic |
Bernard-Soulier syndrome type C, Bernard Soulier syndrome |
| RS5030773 |
LHB
|
Health Risk |
Pathogenic |
Isolated lutropin deficiency, Isolated lutropin deficiency |
| RS5030776 |
FSHB
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 24 without anosmia, Hypogonadotropic hypogonadism 24 without anosmia |
| RS5030777 |
FSHB
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 24 without anosmia, Hypogonadotropic hypogonadism 24 without anosmia |
| RS5030802 |
VHL
|
Health Risk |
Likely pathogenic |
Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome |
| RS5030803 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS5030804 |
VHL
|
Health Risk |
Likely pathogenic |
Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome |
| RS5030805 |
VHL
|
Health Risk |
Pathogenic/Likely pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS5030807 |
VHL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Von Hippel-Lindau syndrome |
| RS5030808 |
VHL
|
Health Risk |
Pathogenic |
Pheochromocytoma, Von Hippel-Lindau syndrome |
| RS5030809 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome |
| RS5030810 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS5030811 |
VHL
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS5030812 |
VHL
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Chuvash polycythemia |
| RS5030813 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS5030814 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS5030816 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Hereditary cancer-predisposing syndrome |
| RS5030817 |
VHL
|
Health Risk |
Pathogenic/Likely pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |